https://www.selleckchem.com/pr....oducts/pkm2-inhibito
The volumes of normal tissue receiving high (≥80% of prescription dose or ≥40 Gy) or intermediate (80%dose≥50% of the prescription dose or 40Gydose≥25Gy) dose were significantly smaller with CK vs. IMRT plans (p less then 0.0001 for all comparisons). With a median follow-up of 3.7 (range 0.1-9. years, 3-year LC was 92% for all patients. Eight failures occurred one craniopharyngioma (marginal), two ependymomas (both in-field), and five low-grade gliomas (2 in-field, 1 marginal, and 2 distant). Conclusions Fra
Like
Comment
Share
